glutathione pathway to triple negative cancer

glutathione pathway to triple negative cancer depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment surmount triple-negative breast Glutathione and Thioredoxin Antioxidant Pathways

Name: glutathione pathway to triple negative cancer depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment surmount triple-negative breast Glutathione and Thioredoxin Antioxidant Pathways
Brand: iglepidom.org
SKU: 65923273031
Price: 26.12 USD
Availability: InStock
Rating: 4.8613 (12 reviews)

Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis World Journal of Surgical Oncology Springer Nature Link Salidroside sensitizes Triple negative breast cancer to ferroptosis by SCD1 mediated lipogenesis and NCOA4 mediated ferritinophagy ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy

SKU: 65923273031 · From iglepidom.org

4.9

USD26.12 USD61.12

Pay in 4 interest-free payments of $6.53 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Description

It was found that transgenic mice developed HCC, which subsided when the transgene was inhibited, which showed that Met over-expression induced tumorigenesis without HGF